Working… Menu
Trial record 1 of 1 for:    NCT03057977
Previous Study | Return to List | Next Study

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03057977
Recruitment Status : Recruiting
First Posted : February 20, 2017
Last Update Posted : October 16, 2019
Eli Lilly and Company
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 19, 2020
Estimated Study Completion Date : July 20, 2020